Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Mapping and predicting mortality from systemic sclerosis
Indexado
Scopus SCOPUS_ID:85030983267
DOI 10.1136/ANNRHEUMDIS-2017-211448
Año 2017
Tipo

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc). Methods Between 2000 and 2011, we examined the death certificates of all French patients with SSc to determine causes of death. Then we examined causes of death and developed a score associated with all-cause mortality from the international European Scleroderma Trials and Research (EUSTAR) database. Candidate prognostic factors were tested by Cox proportional hazards regression model by single variable analysis, followed by a multiple variable model stratified by centres. The bootstrapping technique was used for internal validation. Results We identified 2719 French certificates of deaths related to SSc, mainly from cardiac (31%) and respiratory (18%) causes, and an increase in SSc-specific mortality over time. Over a median follow-up of 2.3 years, 1072 (9.6%) of 11 193 patients from the EUSTAR sample died, from cardiac disease in 27% and respiratory causes in 17%. By multiple variable analysis, a risk score was developed, which accurately predicted the 3-year mortality, with an area under the curve of 0.82. The 3-year survival of patients in the upper quartile was 53%, in contrast with 98% in the first quartile. Conclusion Combining two complementary and detailed databases enabled the collection of an unprecedented 3700 deaths, revealing the major contribution of the cardiopulmonary system to SSc mortality. We also developed a robust score to risk-stratify these patients and estimate their 3-year survival. With the emergence of new therapies, these important observations should help caregivers plan and refine the monitoring and management to prolong these patients' survival.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Rheumatology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Elhai, Muriel Mujer Université de Paris - Francia
Université Paris Cité - Francia
2 Meune, Christophe Hombre Paris XIII University - Francia
University Sorbonne Paris Nord - Francia
3 Boubaya, Marouane Hombre University Hospital of Paris Seine-Saint-Denis - Francia
4 Avouac, Jérôme Hombre Université de Paris - Francia
Université Paris Cité - Francia
5 Hachulla, Eric Hombre University of Lille - Francia
Université de Lille - Francia
6 Balbir-Gurman, Alexandra Mujer The Ruth and Bruce Rappaport Faculty of Medicine - Israel
Rambam Health Care Campus Israel - Israel
7 Riemekasten, Gabriela Mujer Universität zu Lübeck - Alemania
8 Airò, Paolo Hombre Spedali Civili Di Brescia - Italia
9 Joven, Beatriz Mujer Hospital Universitario 12 de Octubre - España
10 Vettori, Serena Mujer
11 Cozzi, Franco Hombre Università degli Studi di Padova - Italia
12 Ullman, Susanne Mujer Copenhagen University Hospital - Dinamarca
Bispebjerg Hospital - Dinamarca
13 Czirják, László Hombre Pécsi Tudományegyetem - Hungría
14 Tikly, Mohammed Hombre Baragwanath Hospital - República de Sudáfrica
Chris Hani Baragwanath Hospital - República de Sudáfrica
15 Müller-Ladner, Ulf - Justus Liebig University Giessen - Alemania
Justus-Liebig-Universität Gießen - Alemania
16 Caramaschi, Paola Mujer Università degli Studi di Verona - Italia
Università di Verona Scuola di Medicina e Chirurgia - Italia
17 Distler, Oliver Hombre UniversitatsSpital Zurich - Suiza
18 Iannone, Florenzo Hombre Università degli Studi di Bari - Italia
Università degli studi di Bari Aldo Moro - Italia
19 Ananieva, Lidia P. Mujer V.A. Nasonova Research Institute of Rheumatology - Rusia
20 Hesselstrand, Roger Hombre Skånes universitetssjukhus - Suecia
21 Becvar, Radim Hombre Charles University - República Checa
22 GABRIELLI, Armando Hombre Università Politecnica delle Marche - Italia
23 Damjanov, Nemanja Hombre University of Belgrade - Serbia
24 Salvador, Maria J. Mujer Centro Hospitalar e Universitário de Coimbra - Portugal
25 Riccieri, Valeria Mujer Università degli Studi di Roma La Sapienza - Italia
Sapienza Università di Roma - Italia
26 Mihai, Carina Mujer Universitatea de Medicina si Farmacie Carol Davila din Bucuresti - Rumania
27 Szucs, Gabriela Mujer Debreceni Egyetem Általános Orvostudományi Kar - Hungría
Általános Orvostudományi Kar - Hungría
28 Walker, Ulrich A. Hombre Universitat Basel - Suiza
Universitätsspital Basel - Suiza
29 Hunzelmann, Nicolas Hombre Uniklinik Köln - Alemania
30 Martinovic, Duska - Clinical Hospital Split - Croacia
Klinički Bolnički Centar Split - Croacia
31 Smith, Vanessa Mujer Universiteit Gent - Bélgica
32 Müller, Carolina De Souza Mujer Universidade Federal do Paraná - Brasil
33 Montecucco, Carlo Maurizio Hombre Fondazione IRCCS Policlinico San Matteo - Italia
34 Opris, Daniela Mujer Universitatea de Medicina si Farmacie Carol Davila din Bucuresti - Rumania
35 Ingegnoli, Francesca Mujer Università degli Studi di Milano - Italia
36 Vlachoyiannopoulos, Panayiotis G. Hombre University of Athens Medical School - Grecia
School of Medicine - Grecia
37 Stamenkovic, Bojana Mujer Institute for Prevention - Serbia
38 Rosato, Edoardo Hombre Università degli Studi di Roma La Sapienza - Italia
Sapienza Università di Roma - Italia
39 Heitmann, Stefan Hombre Marien Hospital Stuttgart - Alemania
40 Distler, Jörg H.W. Hombre Universitätsklinik Erlangen und Medizinische Fakultät - Alemania
Universitätsklinikum Erlangen - Alemania
41 Zenone, Thierry Hombre Unit of Internal Medicine - Francia
42 Seidel, Matthias Hombre Universitäts-Klinikum Bonn und Medizinische Fakultät - Alemania
Universitätsklinikum Bonn - Alemania
43 Vacca, Alessandra Mujer University Hospital of Cagliari - Italia
44 Langhe, Ellen De Mujer KU Leuven– University Hospital Leuven - Bélgica
45 Novak, Srdan - Klinički Bolnički Centar - Croacia
Klinički Bolnički Centar Rijeka - Croacia
46 Cutolo, Maurizio Hombre Università degli Studi di Genova - Italia
47 Mouthon, Luc - Hopital Cochin AP-HP - Francia
48 Henes, Jörg Hombre Universitätsklinikum Tübingen Medizinische Fakultät - Alemania
Universitätsklinikum und Medizinische Fakultät Tübingen - Alemania
49 Chizzolini, Carlo Hombre Hôpitaux universitaires de Genève - Suiza
University Hospital - Suiza
50 Mühlen, Carlos Alberto Von Hombre Rheuma Clinic Av Carlos Gomes Porto Alegre - Brasil
51 Solanki, Kamal Hombre University of Waikato - Nueva Zelanda
The University of Waikato - Nueva Zelanda
52 Rednic, Simona Mujer Universitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napoca - Rumania
53 Stamp, Lisa Mujer University of Otago - Nueva Zelanda
University of Otago, Christchurch - Nueva Zelanda
54 Anić, Branimir Hombre University of Zagreb School of Medicine - Croacia
KBC Zagreb - Croacia
55 Santamaria, Vera Ortiz Mujer Rheumatology Granollers General Hospital - España
56 Santis, Maria De Mujer Humanitas Research Hospital - Italia
57 Yavuz, Sule - Marmara Üniversitesi - Turquía
58 Sifuentes-Giraldo, Walter Alberto Hombre Hospital Ramon y Cajal - España
Hospital Universitario Ramón y Cajal - España
59 Chatelus, Emmanuel Hombre Hopital de Hautepierre - Francia
60 Stork, Jiri - Všeobecná Fakultní Nemocnice V Praze - República Checa
Všeobecná Fakultní Nemocnice v Praze - República Checa
61 Laar, Jacob Van Hombre The James Cook University Hospital - Reino Unido
62 Loyo, Esthela - Hospital Regional Universitario Jose Ma Cabral y Baez - Chile
63 De La Peña Lefebvre, Paloma Garcia Mujer Universidad Autónoma de Madrid - España
Hospital Universitario Madrid Norte Sanchinarro - España
64 Eyerich, Kilian Hombre Technical University of Munich - Alemania
Technische Universität München - Alemania
65 Cosentino, Vanesa Mujer Universidad de Buenos Aires - Argentina
66 Alegre-Sancho, Juan Jose Hombre Hospital Universitario Dr. Peset - España
67 Kowal-Bielecka, Otylia Mujer Uniwersytet Medyczny w Bialymstoku - Polonia
68 Rey, Grégoire Hombre INSERM - Francia
69 Matucci-Cerinić, Marco Hombre Università degli Studi di Firenze - Italia
Università degli Studi di Firenze, Facoltà di Medicina e Chirurgia - Italia
70 Allanore, Yannick Hombre Université de Paris - Francia
Université Paris Cité - Francia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Institut National de la Santé et de la Recherche Médicale
Institut National de la Santé et de la Recherche Médicale
French national Health and Medical research Institute

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Funding this study was funded by the “Institut national de la santé et de la recherche médicale (InSErM)” (French national Health and Medical research Institute).
Competing interests od reports personal fees from 4d Science, grants and personal fees from Actelion, personal fees from Active Biotech, grants and personal fees from Bayer, personal fees from Biogen Idec, personal fees from BMS, grants and personal fees from Boehringer Ingelheim, personal fees from ChemomAb, personal fees from Epipharm, personal fees from Esperare Foundation, personal fees from Genentech/roche, personal fees from GSK, personal fees from Inventiva, personal fees from Lilly, personal fees from Medac, personal fees from Mepha, personal fees from MedImmune, personal fees from pharmacyclics, grants and personal fees from pfizer, grants and personal fees from Sanofi, personal fees from Serodapharm, personal fees from Sinoxa, personal fees from AbbVie, personal fees from iQone Healthcare, outside the submitted work. In addition, od has a patent mir-29 for the treatment of systemic sclerosis licensed. FI reports personal fees from AbbVie, personal fees from BMS, personal fees from MSd, personal fees from novartis, outside the submitted work. JHWd reports personal fees from Actelion, grants and personal fees from Anamar, grants and personal fees from Bayer pharma, grants and personal fees from Boehringer Ingelheim, grants from Celgene, personal fees from Galapagos, grants from GSK, grants and personal fees from Inventiva, personal fees from pfizer, grants and personal fees from UCB, grants from novartis, other from 4d Science, outside the submitted work. JvL reports personal fees from pfizer, grants and personal fees from MSd, personal fees from Eli Lilly, personal fees from BMS, personal fees from roche, outside the submitted work. other coauthors have nothing to disclose.

Muestra la fuente de financiamiento declarada en la publicación.